|
|
|
Pinpointing Key Proteins in Blood Stem Cell Replication A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules. The blood stem cells' misguided enthusiasm also inhibits their ability to successfully repopulate the immune system of a recipient animal after a bone marrow transplant - a common leukemia treatment. The discovery is the first to directly link the notorious members of the retinoblastoma family of proteins to the cellular production factories responsible for churning out all the blood and immune cells in the body. "This is an important step in understanding the initiation of human cancer at a cellular level," said Patrick Viatour, PhD, a postdoctoral scholar who performed the research in the laboratory of Julien Sage, PhD. Sage, assistant professor of pediatrics and of genetics, recently received a SEED grant from the California Institute of Regenerative Medicine to investigate how the retinoblastoma, or Rb, proteins affect human embryonic stem cells. Viatour is the first author of the research, which was published in the Oct. 9 issue of Cell Stem Cell. "These studies, and additional experiments from our lab in other tissues and organs, indicate that Rb proteins play a critical role in suppressing tumors originating in adult stem cells populations," said Sage, who is also a member of the Stanford Cancer Center. The first retinoblastoma protein, pRb, was identified through studies of retinal cancer arising in children in whom the protein is missing or mutated. Since that time, Rb proteins have been shown to be involved in preventing many different types of human cancers. Further study showed that pRb stops a cell from dividing before it has appropriately duplicated and segregated its genetic material - coordinating the complex series of events like a traffic light at a busy intersection. The protein doesn't work alone, however. Two other family members, p107 and p130, also help carry out the important duties. Their ability to fill in for one another makes it difficult to parse out exactly what the proteins are doing at a molecular level. Unfortunately, laboratory animals missing just one or two family members die soon after birth. Viatour and Sage devised a way to inhibit, or knock out, the function of all three proteins in adult mice. They genetically engineered animals in which the p107 gene is deleted and the pRb and p130 genes are flanked by pieces of DNA that are recognized and cleaved by a specialized protein called the Cre recombinase. When expressed in blood stem cells, the recombinase snips out the Rb and p130 genes, leaving these stem cells and their progeny - that is, the entire blood system-without any functional Rb family members. The researchers found that blood, or hematopoetic, stem cells in the mice, which usually hang around quietly waiting to be called into action, began actively proliferating when Rb family members were missing. And while unmodified blood stem cells give rise to two main groups of cells - myeloid and lymphoid - the cells missing the Rb family strongly favored the myeloid lineage. "The differentiation of these hematopoetic stem cells is clearly defective," said Viatour, who also collaborated with bioinformatician and pediatrician Atul Butte, MD, PhD, and many other Stanford researchers on the work. Butte, an assistant professor of medicine and pediatrics, helped the researchers investigate the gene expression profiles of the blood stem cells. "We found that key myeloid genes were upregulated in the cells, and that lymphoid-associated genes were downregulated," said Viatour. In contrast, the ability of the stem cells to make more of themselves seems unimpaired. Finally, in an experiment mimicking human bone marrow transplantation, hematopoetic stem cells from the mice missing the Rb family members were no longer able to repopulate the immune systems of animals that had received a lethal dose of radiation. "It's been known that resting, or quiescent, stem cells are much more likely to be successful candidates for transplantation in both humans and mice than are actively dividing cells," said Viatour. "We now have a good model for understanding why that is." |
|
Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth. The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes. The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 2 million visitors each month. ![]() The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!
Home
History Bibliography Pregnancy Timeline Prescription Drug Effects on Pregnancy Pregnancy Calculator Female Reproductive System Contact The Visible Embryo News Alerts Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
|
In the U.S., 1,000 to 2,000 children are born with anencephaly each year. Most do not survive more than a day or two. Although anencephaly can sometimes be diagnosed through ultrasound, which picks up the malformation of the head, there is no genetic test, and its cause is unknown. By breeding special "knockout" mice that were missing the gene for the enzyme called HSD17b7, UIC researchers found that such mice died on the tenth day of gestation with the severe lack of brain development that characterizes the human birth defect.
The failure of the mice to develop, as well as the extreme changes in the formation of the animals, was very surprising, said Geula Gibori, UIC distinguished professor of physiology and biophysics and principal investigator of the study. Mice that lack enzymes of similar function are born with subtle changes in their cognitive ability, but they survive. The UIC researchers had Previous UIC research had discovered this novel enzyme and focused on its role in converting the weak hormone estrogen into the more potent estradiol in the ovaries and its possible role in breast cancer.
Recent research has shown that the HSD17b7 enzyme has an additional role in the last steps of cholesterol biosynthesis. But because the fetus receives cholesterol from the mother during gestation, Gibori and her colleagues did not expect the enzyme to be of much importance to development. However, it appears that as the fetal mouse brain develops it forms a blood barrier, blocking maternal cholesterol from brain cells. The brain becomes dependent on the biosynthesis of its own cholesterol once this blood-brain barrier forms, at day 10 of gestation.
The UIC researchers established that in the fetus, the brain is the most important site for HSD17b7 expression and provided evidence that anencephaly may result from the loss of this enzyme. "Creating a knockout mouse is a very laborious process," said Aurora Shehu, first author of the paper and at that time a graduate student in Gibori's laboratory. Mice with only one copy of the gene are produced and then interbred; one in four of their offspring should have no copy of the gene - a "null" mouse.
"We expected null mice to be born and to be infertile, however, no null mice were born," said Shehu. "I was afraid I had made a mistake, and went back to the beginning, repeating the entire process, but still no null mice were born." Shehu then began more painstaking work, performing in-utero genetic testing on entire litters - often 10 to 12 fetuses per litter. She found that the null mice were there, but they were dying at day 10 of gestation, when the blood-brain barrier develops.
Gibori says the gene that is missing or defective in human anencephaly is not yet known, but the discovery that the deletion of HSD17b7 in the mouse causes anencephaly suggests this gene may be awry in the human disease. "This opens up very exciting possibilities for understanding human anencephaly, and, perhaps, someday being able to provide a genetic test for the condition early in pregnancy - and ultimately a therapy," she said. As their next step, Gibori's lab plans to test human anencephalic tissue for a mutation in the HSD17b7 gene.
Good Communication Between Neurons and Muscle Cells
You can't raise a finger without your brain directing muscle cells, and scientists have figured out another reason that usually works so well. A neuron sends a message, or neurotransmitter, to the muscle cell to tell it what to do. To get the message, the receiving cell must have a receptor. Oddly, the unstable protein rapsyn is responsible for anchoring the receptor so it's properly positioned to catch the message.
Medical College of Georgia scientists have found what keeps rapsyn in proper conformation. It is a heat shock protein, one of a large family of molecular chaperones that make sure proteins get where they are needed and do what they should, says Dr. Lin Mei, chief of developmental neurobiology at MCG and Georgia Research Alliance Eminent Scholar in Neuroscience.
Hsp90β helps stabilize rapysn so receptors can get and stay where needed, according to research published in the Oct. 9 issue of Neuron. Dr. Mei suspects that other hsp siblings have a similar caretaker role in neuron-to-neuron communication in the brain.
Scientists knew rapsyn's role in getting neuromuscular receptors to aggregate and stay where needed, but they didn't know what stabilized it. "It makes you wonder how to control this naughty boy which is very important," says Dr. Mei, the study's corresponding author. They found hsp90β wherever rapsyn clustered in muscle cells. When they disrupted its activity or expression, they realized hsp90β's stabilizing role in forming and maintaining receptor clusters, says Dr. Shiwen Luo, postdoctoral fellow in Dr. Mei's lab and the study's first author. Rapsyn and the receptor apparently interact, then hsp90β comes along to help stabilize the relationship.
Rapsyn mutations have been implicated in muscular dystrophies including congenital myasthenia gravis. MCG researchers are looking now to see if a mutated rapsyn still interacts with hsp90β.
They used a type of acetylcholine nicotinic receptor at the neuromuscular junction as a model for their studies of brain development and communication. The junction is 1,000 times larger than connections, or synapses, between two neurons but structurally similar. Fundamentals include presynaptic terminals that release neurotransmitters picked up by receptors on the postsynaptic side. Terminals and receptors must be lined up well, whether it's a muscle cell or neuron getting the message. "In central nervous system synapses and at the neuromuscular junction, receptors have to be concentrated at the right spot to receive the neurotransmitter released," says Dr. Mei. If receptors are in the wrong place, the message can be weak or even lost.
At the neuromuscular juncture, communication is usually straightforward, with primarily one neurotransmitter and one principal receptor. "Whenever you tell a muscle to move, it moves. If you want your muscles to think, you wouldn't be able to pick up a pin," says Dr. Mei. In the brain, where neurons have thousands of synapses, it's more of a negotiation. "Signals have to be integrated in the neuron for it to decide what to do."
|